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Background: Our previous studies have suggested that the primary impact of immune cell infiltration into the
normal or pre-invasive tissue component is associated with the physical destruction of epithelial capsules, which
may promote tumor progression and invasion. Our current study attempted to further verify our previous
observations and determine the primary type(s) of infiltrating immune cells and the possible mechanism associated
with physical destructions of the epithelial capsules.
Methods: In total, the study was conducted with 250 primary breast and prostate tumors, the primary immune cell
of cytotoxic T-lymphocytes (CTL), Natural killer cells (NK) and Mast cells were analyzed by immunohistochemistry,
fluorescent labeling and apoptosis assay. qRT-PCR was used for gene expression analysis. Our current study
assessed the physical disruption of these immune cells and potential impact on the epithelial capsule of human
breast and prostate tumors.
Results: Our study yield several clinically-relevant findings that have not been studied before. (1) A vast majority
of these infiltrating immune cells are distributed in the normal-appearing or pre-invasive tissue components
rather than in invasive cancer tissues. (2) These cells often form rings or semilunar structures that either surround
focally-disrupted basal cell layers or physically attach to the basal cells. (3) Basal cells physically associated with
these immune cells generally displayed distinct signs of degeneration, including substantially elevated apoptosis,
necrosis, and reduced tumor suppressor p63 expression. In contrast, luminal cells overlying focally disrupted basal
cell layers had a substantially increased proliferation rate and elevated expression of stem cell markers compared
to their adjacent morphologically similar counterparts that overlie a non-disrupted capsule.
Conclusion: Our findings suggest that at the early stage of tumor invasion, CTL, NK and Mast cells are the main
types of tumor infiltrating immune cells involved in focal degenerative products in the tumor capsules. The
primary impact of these infiltrating immune cells is that they are associated with focal disruptions of the tumor
capsule, which selectively favor tumor stem cells proliferation and invasion.
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The impact and clinical significance of tumor-infiltrating
immune cells remain a hot topic after decade of de-
bate. A large number of publications have reported
that the direct physical contact between infiltrated
immune cells and tumor cells is associated with the
physical destruction of associated tumor cells, reduc-
tion of the tumor size, and significantly improved
clinical prognoses [1-6]. However, an increasing num-
ber of publications show that increased infiltration of
immune cells may promote tumor progression and in-
vasion. Previous reports that stage and histopathologic-
ally matched pre-invasive prostate and esophageal
tumors with increased immune cell infiltration have a
significantly higher frequency of subsequent progres-
sion to invasive lesions, compared to their counter-
parts without immune cell infiltration [7-9]. It has
also been reported: (a) macrophages can enhance can-
cer cell migration through secretion of chemotactic
and chemokinetic factors that promote fibrillogenesis
and angiogenesis, allowing tumor cells to track along
collagen fibers and blood vessels [10,11], (b) macro-
phages ingest tumor cells induce a mixture of genetic
materials and create a hybrid phenotype which can
metastasize to remote sites to form new colonies [12],
(c) T-lymphocytes promote invasion and metastasis by
regulating tumor-associated macrophages [13]; (d) in-
filtration of immune cells can export growth factors
and other proliferation-related molecules to associated
tumor cells through direct physical contact and pro-
mote epithelial-mesenchymal transition (EMT) and
cell motility [14,15].
The contradictory observations regarding the im-
pact of tumor-infiltrating immune cells have caused
confusions in judging the clinical implications of ab-
errant infiltration of immune cells within tumor tis-
sues. In addition, as immune cell-mediated lysis or
cytotoxic assays are almost exclusively conducted on
cell cultures or animal models, these in vitro assays
cannot fully mimic the intrinsic events in human car-
cinogenesis [16-18]. It has been well documented that
the immune-surveillance systems differ significantly in
human and animals [19,20].
We have speculated that these contradictory re-
ports and statements may result from different tumor
stages, in which infiltrating immune cells may be as-
sociated with differential consequences depending on
the cell type. To validate our speculation, our previous
studies compared the pattern and frequency of physical
association of tumor-infiltrating immune cells with
basal and luminal cells of breast and prostate tumors
that harbor both pre-invasive and invasive components.
Our studies revealed that: (1) over 90% of infiltrating
immune cells were distributed in the normal or pre-invasive tissue component, while fewer than 10% were
in the invasive tissue component, (2) within the normal
or pre-invasive tissue component, over 90% of the
epithelial structures with a focally disrupted epithelial
capsule were associated with infiltrating immune cells,
compared to about 30% in epithelial structures with a
non-disrupted capsule, (3) a vast majority of infiltrat-
ing immune cells were located on or near the site of
focally disrupted epithelial capsules, and (4) epithelial
cells overlying focally disrupted capsules often show a
substantially increased proliferation rate and often
form finger- or tongue-like projections invading the
adjacent stroma [21-25]. Based on these and other
findings, we have hypothesized that the primary im-
pact of immune cell infiltration into normal or pre-
invasive tissue component is the physical destruction
of epithelial capsules, which may promote tumor pro-
gression and invasion [26,27].
Our current study attempted to further verify our pre-
vious observations and determine the primary type(s)
of infiltrating immune cells and the possible mechan-
ism(s) associated with physical destructions of the
epithelial capsules. As it has been well documented
that: (1) CTL, natural killer (NK) and Mast cells are the
primary immune cell types for detecting and eliminat-
ing degenerated and altered host cells and (2) these
three cell types harbor similar cytotoxic granules and
share the same mechanism for the exocytosis of their
granules [28-31], we have hypothesized they may be
preferentially localized on degenerated basal cell layers
and function coordinately in the physical destruction of
degenerated epithelial capsules.
Methods
Formalin-fixed, paraffin-embedded human breast tissue
(N = 150) were retrieved from the files of the Depart-
ment of Pathology and Department of Oncology, the
Affiliated Nanjing Maternity and Child Health Care
Hospital, Nanjing Medical University. Human prostate
(N = 100) tumor tissue blocks were obtained from
Department of Pathology, Affiliated Jiangsu people’s
hospital, Nanjing Medical University with an IRB ap-
proval from Nanjing Medical University.
Serial 5-7 μm sections were made from the breast and
prostate tumor tissue blocks. The first and last sections
from each block were stained with Hematoxylin & Eosin
(H&E) for morphological classification using published
criteria. Double immunohistochemistry was applied to
assess the potential impact of infiltrating immune cells
on other cell types and structures using previously pub-
lished protocol [32]. The secondary antibody, ABC de-
tection kit and diaminobenzidine chromogen kit were
obtained from Vector Laboratories (Burlingame, CA,
USA). The AP red-chromogen kit was purchased from
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Negative control slides (IgG only) were included in each
individual analysis.
Immune cell aggregates and tumor infiltrating im-
mune cells were elucidated with leukocyte common
antigen (LCA, clone: 2B11 + PD7/26; Dako, Carpinteria,
CA, USA), CD8 (clone: C8144B), CD16 (clone: DJ130c)
and Mast cell tryptase (clone: AA1) (Dako). The breast
myoepithelial and prostate basal cells were identified
with smooth muscle actin (SMA; clone: 1A4; Sigma,
USA) and cytokeratin (CK34βE12 (clone: M0630; Dako)
respectively. The focal capsule disruptions were defined
as the presence of a physical gap in a given myoepithelial
or basal cell layer that is larger than the combined size
of at least three epithelial cells and in at least threeFigure 1 Lymphocyte aggregates in normal or hyperplastic breast an
prostate (C-D) tissue sections were double immunostained for smooth mu
antigen (LCA; brown) or cytokeratin (CK) 34βE12 (a basal cell marker; red) p
associated with normal or hyperplastic epithelial structures, whereas the in
(arrows). A and C: 100X. B and D: a higher (300X) magnification of A and Cconsecutive sections. Physical signs of degeneration-
related changes were defined as the loss of expression
of phenotypic markers, vacuolation, fragmentation,
swelling, nuclear membrane breakage, chromatin con-
densation, atrophy, and necrosis. To assess the poten-
tial impact of physical association between infiltrated
immune cells and basal or luminal cells, immuno-
stained sections and photographs were independently
reviewed by three investigators. A given cell was con-
sidered immunoreactive if distinct immunoreactivity
was consistently present in its cytoplasm, membrane or
nucleus while absent in all negative controls. All in-
filtrated immune cell aggregates in each case were
counted, the frequencies of these aggregates within pre-
invasive and invasive tissue components were statisticallyd prostate tissues. Paraffin-embedded human breast (A-B) and
scle actin (SMA; a myoepithelial marker; red) plus leukocyte common
lus LCA. Note that lymphocyte aggregates (circles) are exclusively
vasive component (stars) only harbors a few isolated lymphocytes
, respectively.








154 7 (4.5%) 147 (95.5%) <0.01
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pare the frequencies of cytological signs of degener-
ation in basal and luminal cells that are physically
associated with infiltrated immune cells, digital im-
ages were taken in 3–5 randomly selected basal cell
layers and associated luminal cells subjacent to or
surrounded by infiltrated immune-cells. Digital images
were enlarged and viewed on a computer to detect po-
tential signs of degeneration defined as above. The totalFigure 2 Lymphocyte infiltration within in situ breast and prostate ca
(C-D) tissue sections were double immunostained for SMA (red) plus LCA (
although these in situ breast and prostate tumor nests (stars) are almost co
majority of the tumor cells are physically separated from the surrounding i
basal cell layer) (arrowheads). A and C: 100X B and D: a higher (300X) magnumbers of cells counted and cells with cytological
signs of degeneration in each group were added and av-
eraged, the averaged frequencies were statistically com-
pared by the Pearson’s Chi-square test. Statistical
significance was defined as p < 0.05.
To assess the biological and molecular changes along
with potential mechanisms caused by the physical asso-
ciation between infiltrating immune cells and the basal
or luminal cells, the following technical approaches were
utilized:
(A)Apoptosis assay. Tissue sections from 10 cases with
a high frequency of degeneration-related changes in
the basal cell layers were subjected to apoptosis
detection with Apoptosis Detection Kitncer tissues. Paraffin-embedded human breast (A-B) and prostate
brown) or CK34βE12 (a basal cell marker; red) plus LCA. Note that
mpletely surrounded by infiltrating immune cells (arrows), a vast
nfiltrating immune cells by the tumor capsule (the myoepithelial or
nification of A and C, respectively.
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manufacturer’ protocol. After wash, the sections
were staining for CK34βE12 to determine the
histological origin of apoptotic cells.
(B) The expression status of tumor suppressor p63
in the basal cell layers: p63 expression in basal
cells within non-disrupted and focally disrupted
residual layers were compared by double
immunostaining of CK34βE12 and p63. To verify
the sub-cellular localization of basal cell
phenotypic makers CK34βE12 and p63, sets of
adjacent human prostate tissue sections from 10
selected cases were double immunostained for
CK34βE12 and p63 (clone: 4A4; Cell Marque,
Rocklin, CA, USA). The antigen-antibodyFigure 3 Lymphocyte infiltration at sites of focal capsule disruptions o
(A-B) and prostate (C-D) tissue sections were double immunostained for SMA
infiltrating lymphocytes (arrows) are located on the site of focally disrupted ep
formed tongue-like projections invading the adjacent stroma. A and C: 100X. Bcomplexes were distinguished by different
secondary antibodies labeled with different
fluorophores (DyLight 488 and Dylight 549; KPL,
Gaithersburg, MD, USA) according to the
manufacturer’s instructions. Immunostained
sections were examined and digital images were
taken in a fluorescent microscope (Fluoview 300;
Olympus America, Inc., Center Valley, PA, USA).
(C)Proliferation index and lymphatic duct density: To
further assess the potential impact of infiltrating
immune cells on cell proliferation and angiogenesis,
tissue sections from 30-selected cases were double
immunostained for CK34βE12 and a cell
proliferation marker, Ki-67 (clone: MM1; Dako).
The proliferation status in epithelial cellsf normal appearing tissues. Paraffin-embedded human breast
(red) plus LCA (brown) or CK34βE12 plus LCA. Note that most
ithelial capsules (circles), in which the overlying epithelial cells
and D: a higher (400X) magnification of A and C, respectively.
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compared to those cells that were distant from
infiltrating immune cells. In addition, special
attention was paid to identify whether proliferating
cells were preferentially located on the site of
focally disrupted basal cell layers.
(D)Microdisection and Quantitative Real-Time PCR
(qRT-PCR): Five unstained adjacent sections or
immunostained sections with pre-invasive tumors
showing extensive focal capsule disruptions and
immune cell infiltration were deparaffinized and
lightly stained with hematoxylin. Guided by
immunostained sections, morphologically similar
pre-invasive lesions with and without extensive
focal capsule disruptions and immune cellFigure 4 Lymphocyte infiltration at sites of focal capsule disruptions of
prostate (C-D) tissue sections were double immunostained for SMA (red) plus
lymphocytes (arrows) are located on the site of focally disrupted epithelial cap
structures invading the adjacent stroma. A and C: 100X. B and D: a higher (400infiltration were microdissected and subjected to
RNA extraction by RNeasy FFPE Kit (Qiagen)
according to the manufacturer’s instructions. Total
RNA (0.5 μg) was reverse transcribed in a total
volume of 20 μl using the Omniscript RT kit
(Qiagen). Quantitative PCR was performed in
triplicate in an ABI-Prism 7700 instrument (Applied
Biosystems, Foster City, CA,USA) using QuantiTect
Sybr green (Qiagen, Gaithersberg, MD, USA)
according to the manufacturer’s protocol. The
appropriate primer sets were listed in Additional
file 1: Table S1. Amplification was confirmed by
ethidium bromide staining of the PCR products
on a 2% agarose gel. The expression of each
target gene was based on five pooled samples,in situ cancer tissues. Paraffin-embedded human breast (A-B) and
LCA (brown) or CK34βE12 plus LCA. Note that most infiltrating
sules (circles), in which the overlying tumor cells formed tongue-like
X) magnification of A and C, respectively.
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expressed as 2−ΔCt, where Ct is the threshold
cycle and ΔCt = CtTarget − Ct GAPDH.
Statistical analysis
Student’s test was performed for two group comparisons.
The data presented represent mean ± SEM. P-value of less
than 0.05 was considered to be statistically significant.
Results
The sub-cellular localization and cell types that reacted
to the antibodies were consistent with those of published
data and specifications of manufactures. All negative
controls were consistently devoid of distinct immuno-
reactivity. The results were highly consistent in dupli-
cates or triplicates. The basal and luminal cells wereFigure 5 Mast and NK cell infiltration in normal or hyperplastic prosta
triple immunostained with markers for CK34βE12 (red), NK (brown), and
(thin arrows) are located along the tumor capsule (arrowheads). A and C: 10distinguishable by morphology and by immunohisto-
chemistry in all study cases. The basal cell population
is characterized by its spindle or elongated shape with
densely stained nucleus, CK34βE12 staining in the
cytoplasm, and p63 staining in nucleus. The luminal
cell population is characterized by its round or oval
shape with lightly stained nucleus harboring distinct
nucleoli. It is devoid of CK34βE12 and p63 expres-
sion. CD16, CD56, Fox3p, Mast, and neutrophils cells
are primarily known as lymphocytes; thus, they have
been collectively referred as infiltrated lymphocytes
below. Both the prostate basal and breast myoepithelial
cells are referred to as basal cells below.
Similar to our previous studies, lymphocyte aggregates
were almost exclusively in some normal appearing or
pre-invasive breast and prostate epithelial structures, inte tissues. Paraffin-embedded human prostate tissue sections were
Mast (blue) cells. Note that a majority of NK (thick arrows) and Mast
0X. B and D: a higher (300X) magnification of A and C, respectively.
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tached to the basal cell layers that were often focally
disrupted or substantially attenuated (Figure 1). In sharp
contrast, significantly fewer infiltrated lymphocytes were
seen within the invasive tissue component, and over 95%
of the invasive cancer cells had no direct physical
contact with infiltrated lymphocytes. In a total of 154
lymphocyte aggregates detected near epithelial struc-
tures, 147 (95.5%) were associated with normal or
pre-invasive epithelial structures with focally disrupted
capsules, only 7 (4.5%) were located at the invasive can-
cer component (Table 1; p < 0.01).
Within the in situ breast and prostate cancer tissue com-
ponent, infiltrating immune cells often formed ring or
semilunar structures, completely or partially surrounding
the epithelial tissue. As shown in Figure 2, many infiltratingFigure 6 Mast and NK cell infiltration within in situ prostate tissues. P
immunostained with markers for CK34βE12 (red), NK (brown), and Mast (b
(thin arrows) are located along the tumor capsule (arrowheads).immune cells are physically attached to the epithelial cap-
sules, while the epithelial component is generally free of in-
filtrating immune cells if the surrounding epithelial capsule
is not focally disrupted.
In normal or hyperplastic epithelial structures with a
focally disrupted epithelial capsule, a majority of infil-
trating immune cells was located on or near the site of
focal capsule disruptions. This observation is shown in
Figure 3, in which the overlying epithelial cells formed
finger- or tongue-like projections physically associated
with the adjacent stromal tissue.
In pre-invasive cancerous epithelial structures with a
focally disrupted tumor capsule, infiltrating immune
cells were also preferentially located on the site of focally
disrupted capsules. As shown in Figure 4, the tumor
capsules display distinct signs of degenerative changes,araffin-embedded human prostate tissue sections were triple
lue) cells. Note again that a majority of NK (thick arrows) and Mast
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whereas the overlying epithelial cells appear to have an
elevated proliferation rate, judged from the increased
cell density.
The predominant type of infiltrating immune cells as-
sociated with focal capsule disruptions appears to be
CTL, which can be easily recognized by their morph-
ology and immunoreactivities to the anti-CD8 antibody.
As shown in Figure 5, similar to CTL, a majority of infil-
trating NK and Mast cells in the field are physically
attached to the epithelial capsules of normal or hyper-
plastic epithelial structures. At NK and Mast cell
attaching site, the associated capsules were generally at-
tenuated, fragmented or disrupted. It was interesting to
note that NK and Mast cells often appeared as pairs and
localized on the same site.Figure 7 Elevated apoptosis in focally disrupted basal cell layers. Para
apoptosis assay and also immuostaining for basal cell markers. Note that n
(arrowheads), the basal cells. A and C: 100X. B and D: a higher (300X) magSimilar NK and Mast cell infiltration was also seen in
pre-invasive cancerous epithelial structures. As shown in
Figure 6, a number of NK and Mast cells lied along with
the capsule and physically associated with epithelial cells
overlying focally disrupted capsules, whereas the epithe-
lial component is largely free of Mast cells.
Focal capsule disruptions appear to result from focal
degenerative alterations in the constitutional elements of
the epithelial capsule. As shown in Figure 7, apoptotic
cells are exclusively seen in the basal cell layers sur-
rounding the epithelial component, which is largely de-
void of or have significantly fewer apoptotic cells.
Compared to their non-disrupted counterparts, the re-
sidual basal cells in focally disrupted capsule have sig-
nificantly lower expression of tumor suppressor p63. As
shown in Figure 8, a majority of the basal cells withinffin-embedded human prostate tissue sections were subjected to
early all apoptotic cells (arrows) are the epithelial capsule element
nification of A and C, respectively.
Figure 8 Loss of p63 expression in basal cells detected by chromogrn-based immunostaing. Human prostate tissue sections were double
immunostained for CK 34βE12 plus p63. Note that a majority of basal cells in non-disrupted layers have the expression of CK 34βE12 plus p63
(arrowheads), whereas nearly all those cells near the focally disrupted (circles) layers are devoid expression of tumor suppressor p63 (arrows).
A and C: 200X. B and D. A higher (500X) of A and C, respectively.
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p63, whereas only CK34βE12 is expressed in majority
when the capsule is undisrupted. In addition, these
undisrupted cells generally display distinct signs of de-
generation including the loss of morphological integrity,
fragmentations, and necrosis (Figure 8). These degen-
erative alterations were more clearly appreciable in
fluorescent-based immunohistochemistry. As shown in
Figure 9, a substantial reduction of the CK34βE12 and
p63 expression is seen in a large fragment of a basal
cell, suggesting extensive degeneration in this region,
which was associated with increased immune cell infil-
tration (data not shown).
In contrast to these degenerative changes the epithelial
cells overlying focally disrupted capsules often showedsubstantially increased cell proliferation. As shown in
Figure 10, clusters of multiple Ki-67 expressing cells are
exclusively seen at the site of focal capsule disruptions.
Our qRT-PCR results revealed that microdissected lu-
minal cells overlying focal capsule disruptions have sig-
nificantly higher expression levels of four stem cell
markers (CD133, ly6E, Nanog, Sox 2), which were 6-, 4-,
2- and 6-fold higher, respectively, than their undisrupted
counterparts at a distance from the site of focal capsule
disruptions (Figure 11).
Discussion
The preferential association of tumor-infiltrating lym-
phocytes with the basal cell population appears to result
primarily from focal degeneration and disruption of the
Figure 9 Loss of p63 expression in basal cells detected by fluorescence-based immunostaining. A set of three adjacent human prostate
tissue sections were double immunostained for CK34βE12 and p63, the antigen-antibody complexes were distinguished with secondary
antibodies labeled with different fluorophores (A-F) or a red chromogen (G-H). Note that the basal cells near the up-middle have substantially
reduced expression of both CK34βE12 and p63. A and C: 150X. B and D. A higher (400X) of A and C, respectively.
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shown that compared to its morphologically clear-cut
and undisrupted counterpart, a focally disrupted basal
cell layer has significantly lower expressions of tumor
suppressor p63 and proliferating cell nuclear antigen,
while it has significantly higher frequencies of apoptosis
and degeneration [33]. As shown in Figures 8 and 9, a
vast majority of the basal cells within undisrupted layers
express both CK34βE12 and p63, while most basal cells
within disrupted layers lack p63 expression with distinct
signs of degeneration. Thus, it is very likely that the
basal cells in these patients may belong to an “aged” or
degenerated population, and that the degradation prod-
ucts of these basal cells may function as self-epitopes to
stimulate the production of auto-antibodies or to attractthe migration and infiltration of immune cells. Con-
sistent with our speculation, our recent study has re-
vealed that protease-degraded collagen I fragments of
the breast tumor capsule function as a specific medi-
ator to attract macrophage and other immune cell
infiltration [34].
As the breast and prostate epithelium is normally
devoid of both blood vessels and lymphatic ducts and
the my epithelial or basal cell layer is the sole source
of several tumor suppressors [35-37], a focal degener-
ation or disruption in a given basal cell layer could
cause direct exposure of tumor cells to the tumor
microenvirment complexity, and lead to several focal
alterations with significant consequences, including:
(a) local loss of tumor suppressors and paracrine inhibitory
Figure 10 Elevated proliferation in epithelial cell clusters surrounded by lymphocytes. Human prostate tissue sections were double
immunostained for CK34βE12 plus Ki-67. Note that clusters of multiple proliferating cells are exclusively seen near the site of focally disrupted
epithelial capsules (circles). A and C: 100X. B and D: a higher (300X) magnification of A and C, respectively.
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tages allowing them to escape from programmed cell
death [38]; (b) local increase of immune cells infiltra-
tion, could increase of permeability to oxygen, nutri-
ents, and growth factors, which selectively favors the
proliferation of progenitor/stem cells [39,40]; (c) dir-
ect epithelial stromal cell contact, which augments
the expression of stromal matrix metalloproteinase
(MMP) or other cell adhesion molecules , which fa-
cilitate epithelial to mesenchymal transition (EMT)
and cell motility [41]; (d) direct exposure of the epi-
thelial cells to different cytokines, which facilitates
vasculogenic mimicry and tumor angiogenesis [42],
and (e) direct physical contact between newly formed
cell clusters and stromal cells, which stimulates the
production of tenascin and other host factors such ashepatocyte growth factor(HGF) that facilitate stromal
tissue remodeling and drug resisiance [43-45]. These
alterations can individually or synchronously increase
proliferation and motility in cells overlying such dis-
ruptions. Thus, tumor cell clusters overlying focally
disrupted capsules are very likely to represent a popu-
lation of tumor progenitors with a greater propensity
to progress to invasive or metastatic cancer. CD133
and ly6E have been reported as tumor-initiating cells
(TIC) markers for breast cancer and pancreatic Cancer
[46,47], Nanog and Sox2 are ES cell markers that have
been reported in poorly differentiated breast cancer,
and correlated with poor survival [48]. Elevated expres-
sion of stem cell markers in pre-invasive tumors with
extensive focal capsule disruptions and immune cell in-
filtration suggests that focal capsule disruptions and
Figure 11 CD133, ly6E, Nanog and Sox2 mRNA level was
determined by qRT-PCR. All 4 stem marker were elevated in
focally disrupted capsules.
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exit of stem cells from quiescence, allowing the stem
cells to undergo proliferation and invasion into the ad-
jacent stroma or vascular structures.
Our recent studies have consistently revealed that
15-30% of the patients with non-invasive breast or
prostate tumors harbor epithelial structures that are
morphologically normal or hyperplastic in H&E stained
sections, but they show frequent focal capsule disrup-
tions with budding cells in immunohistochemically
stained sections [26-31]. The intrinsic entity of these
structures is unknown, but they most likely represent
a previously undefined malignant phenotype, or the
direct precursor of malignant lesions. Our results are
consistent with several lines of evidence: (1) mammary
ductal intraepithelial neoplasia (DIN)-flat type is a sub-
tle epithelial alteration characterized by one or a few
layer(s) of atypical cells replacing the native epithelium,
but loss of heterozygosity (LOH) was detected in 17 of
22 (77%) lesions, and monoclonality was established in
the 2 cases analyzed [49]; (2) LOH was detected in
morphologically normal lobules adjacent to breast can-
cers. In 10 cases with LOH at chromosome 3p22-25
in the carcinoma, 6 displayed the same LOH in adja-
cent normal lobules [50], and (3) the prostate tissues
in a subset of aged men or normal-appearing prostate
tissues adjacent to prostate cancer harbored a DNA
phenotype that is identical to invasive and metasta-
sized prostate cancer [51-53]. Together, these findingssuggest that those morphologically normal or hyperplas-
tic appearing breast and prostate epithelial structures
may have accumulated significant genetic abnormalities,
which suggests an early stage of malignant trans-
formation or an increased risk for invasive or meta-
static lesions.
The infiltrated host immune cell classification in com-
bine with some other marker may have a prognostic
value for tumor invasion and metastasis [54]. As the dis-
ruption of the tumor capsule is an absolute prerequisite
for tumor invasion and metastasis, our hypothesis, if
confirmed, is likely to have significant scientific implica-
tions and clinical applications. Furthermore, the elucida-
tion of the molecular profiles of the cell population
overlying focal capsule disruptions may lead to the iden-
tification of clinically relevant surrogate biomarkers that
can be used to distinguish between clinically aggressive
and indolent pre-invasive tumors.Conclusions
Our current study in breast and prostate tumors has
revealed: (1) 154 total lymphocyte aggregates detected
were preferentially associated with pre-invasive struc-
tures that have focally disrupted capsules; (2) infil-
trated lymphocytes were predominantly seen at the
site of focally disrupted tumor capsules; (3) a vast ma-
jority of the basal cells were immediately subjacent to
or physically associated with infiltrating lymphocytes
and displayed a wide variety of cytological signs of de-
generation; and (4) focal tumor capsule disruptions
coupled with lymphocyte infiltration with the stem
cell signature appear to facilitate proliferation and dis-
sociation of the overlying luminal cells. Together, our
findings are consistent with our hypothesis: tumor-
infiltrating lymphocytes are exclusively or preferen-
tially associated with degenerated basal cells in the
initial or early stage of tumor invasion. To our know-
ledge, this is the first report, which suggests that the
primary impact of tumor infiltrating CTL, NK and
Mast cells may be associated with the physical disrup-
tions of the tumor capsule. In addition, our findings
could offer a reasonable explanation for the contra-
dictory reports and statements regarding the impact
and clinical significance of immune cell infiltration
into tumor tissues.Additional file
Additional file 1: Table S1. List of primer sequences for RT-PCR.Competing interests
We declare that we have no competing interests.
Yuan et al. BMC Cancer 2013, 13:258 Page 14 of 15
http://www.biomedcentral.com/1471-2407/13/258Authors’ contributions
Y, H, S and S proposed the hypothesis. Y and H designed and performed the
experiments. W, S and S analyzed and interpreted the data. Y, H, Y, S and S
wrote the manuscript. All authors read and approved the final manuscript.
Authors’ information
Hongyan Yuan and Yi-Hsuan Hsiao these authors contributed equally to this
work, and thus are considered as the co-first author.
Acknowledgments
We appreciate Dr. Xirong Guo for giving comments to the manuscript. Dr.
Yan-gao Man has contributed substantially scientific concept of the role of
immune cells in promoting tumor invasion, and assists to construct the
manuscript. This work was supported by grant SKLRM-KF-1206 from State
Key Laboratory of Reproductive Medicine and by grant 200901083 from
Nanjing Science and Technology foundation, Nanjing, China. The funders
were not involved in experiments design, data collection & analysis and
manuscript writing.
Author details
1Department of Oncology, the Affiliated Nanjing Maternity and Child Health
Care Hospital, Nanjing Medical University, Nanjing, China. 2Institute of
Medicine, Chung Shan Medical University, Taichung, Taiwan. 3Department of
Obstetrics and Gynecology, Changhua Christian Hospital, Changhua, Taiwan.
4Johns Hopkins Bloomberg School of Public Health, Johns Hopkins
University, Baltimore, Maryland, USA. 5Department of Oncology, Georgetown
University, Washington, DC, USA. 6Georgetown University School of
Medicine, Washington, DC, USA.
Received: 27 December 2012 Accepted: 14 May 2013
Published: 25 May 2013
References
1. Baxevanis CN, Dedoussis GV, Papadopoulos NG, Missitzis I, Stathopoulos GP,
Papamichail M: Tumor specific cytolysis by tumor infiltrating lymphocytes
in breast cancer. Cancer 1994, 74(4):1275–1282.
2. Boon T, Coulie PG, Van den Eynde B: Tumor antigens recognized by T cells.
Immunol Today 1997, 18(6):267–268.
3. Van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E,
Van den Eynde B, Knuth A, Boon T: A gene encoding an antigen
recognized by cytolytic T lymphocytes on a human melanoma.
Science 1991, 254(5038):1643–1647.
4. Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E,
Dranoff G, Fuchs CS, Ogino S: Tumour-infiltrating T-cell subsets, molecular
changes in colorectal cancer, and prognosis: cohort study and literature
review. J Pathol 2010, 222(4):350–366.
5. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B,
Kirilovsky A, Nilsson M, Damotte D, et al: Effector memory T cells, early
metastasis, and survival in colorectal cancer. N Engl J Med 2005,
353(25):2654–2666.
6. Suzuki H, Chikazawa N, Tasaka T, Wada J, Yamasaki A, Kitaura Y, Sozaki M,
Tanaka M, Onishi H, Morisaki T, et al: Intratumoral CD8(+) T/FOXP3 (+) cell
ratio is a predictive marker for survival in patients with colorectal cancer.
Cancer Immunol Immunother 2010, 59(5):653–661.
7. Gannot G, Gannot I, Vered H, Buchner A, Keisari Y: Increase in immune cell
infiltration with progression of oral epithelium from hyperkeratosis to
dysplasia and carcinoma. Br J Cancer 2002, 86(9):1444–1448.
8. MacLennan GT, Eisenberg R, Fleshman RL, Taylor JM, Fu P, Resnick MI,
Gupta S: The influence of chronic inflammation in prostatic
carcinogenesis: a 5-year followup study. J Urol 2006, 176(3):1012–1016.
9. Smith CJ, Gardner WA Jr: Inflammation-proliferation: possible
relationships in the prostate. Prog Clin Biol Res 1987, 239:317–325.
10. Pollard JW: Tumour-educated macrophages promote tumour progression
and metastasis. Nat Rev Cancer 2004, 4(1):71–78.
11. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, Graf T, Pollard JW,
Segall J, Condeelis J: A paracrine loop between tumor cells and
macrophages is required for tumor cell migration in mammary tumors.
Cancer Res 2004, 64(19):7022–7029.
12. Pawelek JM, Chakraborty AK: The cancer cell–leukocyte fusion theory of
metastasis. Adv Cancer Res 2008, 101:397–444.13. DeNardo DG, Johansson M, Coussens LM: Immune cells as mediators of
solid tumor metastasis. Cancer Metastasis Rev 2008, 27(1):11–18.
14. Hunter KW, Crawford NP, Alsarraj J: Mechanisms of metastasis. Breast
Cancer Res 2008, 10 Suppl(1):S2.
15. Nauseef JT, Henry MD: Epithelial-to-mesenchymal transition in prostate
cancer: paradigm or puzzle? Nat Rev Urol 2011, 8(8):428–439.
16. Kuppen PJ, Gorter A, Hagenaars M, Jonges LE, Giezeman-Smits KM,
Nagelkerke JF, Fleuren G, Van de Velde CJ: Role of NK cells in adoptive
immunotherapy of metastatic colorectal cancer in a syngeneic rat
model. Immunol Rev 2001, 184:236–243.
17. Liu KJ, Wang CJ, Chang CJ, Hu HI, Hsu PJ, Wu YC, Bai CH, Sytwu HK, Yen BL:
Surface expression of HLA-G is involved in mediating immunomodulatory
effects of placenta-derived multipotent cells (PDMCs) towards natural killer
lymphocytes. Cell Transplant 2011, 20(11–12):1721–1730.
18. Fishman M, Gunther G: Induction of tumor cell resistance to
macrophagemediated lysis by preexposure to non-activated macrophages.
Cell Immunol 1986, 99(1):241–256.
19. Kovacs EJ, Palmer JL, Fortin CF, Fulop T Jr, Goldstein DR, Linton PJ: Aging
and innate immunity in the mouse: impact of intrinsic and extrinsic
factors. Trends Immunol 2009, 30(7):319–324.
20. Padgett EL, Pruett SB: Rat, mouse and human neutrophils stimulated by a
variety of activating agents produce much less nitrite than rodent
macrophages. Immunology 1995, 84(1):135–141.
21. Man YG, Shen T, Zhao Y, Amy Sang QX: Focal prostate basal cell layer
disruptions and leukocyte infiltration are correlated events: A potential
mechanism for basal cell layer disruptions and tumor invasion. Cancer
Detect Prev 2005, 29(2):161–169.
22. Yousefi M, Mattu R, Gao C, Man YG: Mammary ducts with and without
focal myoepithelial cell layer disruptions show a different frequency
of white blood cell infiltration and growth pattern: implications for
tumor progression and invasion. Appl Immunohistochem Mol Morphol
2005, 13(1):30–37.
23. Man YG, Tai L, Barner R, Vang R, Saenger JS, Shekitka KM, Bratthauer GL,
Wheeler DT, Liang CY, Vinh TN, et al: Cell clusters overlying focally
disrupted mammary myoepithelial cell layers and adjacent cells within
the same duct display different immunohistochemical and genetic
features: implications for tumor progression and invasion. Breast Cancer
Res 2003, 5(6):R231–R241.
24. Man YG, Zhang Y, Shen T, Zeng X, Tauler J, Mulshine JL, Strauss BL: cDNA
expression profiling reveals elevated gene expression in cell clusters
overlying focally disrupted myoepithelial cell layers: implications for
breast tumor invasion. Breast Cancer Res Treat 2005, 89(2):199–208.
25. Man YGZC, Wang J: Breast tumor cell clusters and their budding
derivatives show different immunohistochemical profiles during stromal
invasion: implications for hormonal and drug therapies. Cancer Therapy
2006, 4:193–204.
26. Man YG: Focal degeneration of aged or injured myoepithelial cells and
the resultant auto-immunoreactions are trigger factors for breast tumor
invasion. Med Hypotheses 2007, 69(6):1340–1357.
27. Man YG, Gardner WA: Focal degeneration of basal cells and the resultant
auto-immunoreactions: a novel mechanism for prostate tumor progression
and invasion. Med Hypotheses 2008, 70(2):387–408.
28. Cullen SP, Brunet M, Martin SJ: Granzymes in cancer and immunity.
Cell Death Differ 2010, 17(4):616–623.
29. Topham NJ, Hewitt EW: Natural killer cell cytotoxicity: how do they pull
the trigger? Immunology 2009, 128(1):7–15.
30. Waterhouse NJ, Clarke CJ, Sedelies KA, Teng MW, Trapani JA: Cytotoxic
lymphocytes; instigators of dramatic target cell death. Biochem
Pharmacol 2004, 68(6):1033–1040.
31. De Saint BG, Menasche G, Fischer A: Molecular mechanisms of biogenesis
and exocytosis of cytotoxic granules. Nat Rev Immunol 2010, 10(8):568–579.
32. Man YG, Burgar A: An antigen unmasking protocol that satisfies both
immunohistochemistry and subsequent PCR amplification. Pathol Res
Pract 2003, 199:815–825.
33. Hsiao YH, Su YA, Tsai HD, Mason JT, Chou MC, Man YG: Increased
invasiveness and aggressiveness in breast epithelia with cytoplasmic
p63 expression. Int J Biol Sci 2010, 6(5):428–442.
34. O'Brien J, Lyons T, Monks J, Lucia MS, Wilson RS, Hines L, Man YG, Borges V,
Schedin P: Alternatively activated macrophages and collagen remodeling
characterize the postpartum involuting mammary gland across species.
Am J Pathol 2010, 176(3):1241–1255.
Yuan et al. BMC Cancer 2013, 13:258 Page 15 of 15
http://www.biomedcentral.com/1471-2407/13/25835. Man YG: A seemingly most effective target for early detection and
intervention of prostate tumor invasion. J Cancer 2010, 24(1):63–69.
36. Pires MM, Hopkins BD, Saal LH, Parsons RE: Alterations of EGFR, p53 and
PTEN that mimic changes found in basal-like breast cancer promote
transformation of human mammary epithelial cells. Cancer Biol Ther 2013,
14(3):246–253.
37. Brimo F, Epstein JI: Immunohistochemical pitfalls in prostate pathology.
Hum Pathol 2012, 43(3):313–324.
38. Man YG, Stojadinovic A, Mason J, Avital I, Bilchik A, Bruecher B, Protic M,
Nissan A, Izadjoo M, Zhang X, Jewett A: Tumor-infiltrating immune cells
promoting tumor invasion and metastasis: existing theories. J Cancer
2013, 4(1):84–95.
39. Ogino S, Galon J, Fuchs CS, Dranoff G: Cancer immunology-analysis of
host and tumor factors for personalized medicine. Nat Rev Clin Oncol
2011, 8(12):711–719.
40. Ilunga K, Nishiura R, Inada H, El-Karef A, Imanaka-Yoshida K, Sakakura T,
Yoshida T: Co-stimulation of human breast cancer cells with transforming
growth factor-beta and tenasicin-c enhances matrix metalloproteinase-9
expression and cancer cell invasion. Int J Exp Pathol 2004, 85:373–379.
41. Kryczka J, Stasiak M, Dziki L, Mik M, Dziki A, Cierniewski C: Matrix
metalloproteinase-2 cleavage of the β1 integrin ectodomain facilitates
colon cancer cell motility. J Biol Chem 2012, 287(43):36556–36566.
42. Yoshimura A: Signal transduction of inflammatory cytokines and tumor
development. Cancer Sci 2006, 97(6):439–447.
43. Midwood KS, Orend G: The role of tenascin-C in tissue injury and
tumorigenesis. J Cell Commun Signal 2009, 3(3–4):287–310.
44. Verstraeten AA, Mackie EJ, Hageman PC, Hilgers J, Schol DJ, De Jongh GJ,
Schalkwijk J: Tenascin expression in basal cell carcinoma. Brit J Dermt
1992, 127:571–574.
45. Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, Davis A,
Mongare MM, Gould J, Frederick DT, Cooper ZA, Chapman PB, Solit DB,
Ribas A, Lo RS, Flaherty KT, Ogino S, Wargo JA, Golub TR: Tumour micro-
environment elicits innate resistance to RAF inhibitors through HGF
secretion. Nature 2012, 487(7408):500–504.
46. Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski LJ:
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with
cancer stem cell characteristics. Breast Cancer Res 2008, 10(1):R10.
47. Gou S, Liu T, Wang C, Yin T, Li K, Yang M, Zhou J: Establishment of clonal
colony-forming assay for propagation of pancreatic cancer cells with
stem cell properties. Pancreas 2007, 34:429–435.
48. Ben-Porath I, Thomson MW, Carey VJ, Gxxe R, Bell GW, Regev A, Weinberg RA:
An embryonic stem cell-like gene expression signature in poorly
differentiated aggressive human tumors. Nat Genet 2008, 40:499–507.
49. Moinfar F, Man YG, Bratthauer GL, Ratschek M, Tavassoli FA: Genetic
abnormalities in mammary ductal intraepithelial neoplasia-flat type
(“clinging ductal carcinoma in situ”): a simulator of normal mammary
epithelium. Cancer 2000, 88(9):2072–2081.
50. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS: Loss of heterozygosity
in normal tissue adjacent to breast carcinomas. Science 1997,
274(5295):2057–2059.
51. Malins DC, Gilman NK, Green VM, Wheeler TM, Barker EA, Vinson MA,
Sayeeduddin M, Hellström KE, Anderson KM: Metastatic cancer DNA
phenotype identified in normal tissues surrounding metastasizing
prostate carcinomas. Proc Natl Acad Sci 2004, 101:11428–11431.
52. Malins DC, Anderson KM, Gilman NK, Green VM, Barker EA, Hellström KE:
Development of a cancer DNA phenotype prior to tumor formation.
Proc Natl Acad Sci 2004, 101:10721–10725.
53. Malins DC, Gilman NK, Green VM, Wheeler TM, Barker EA, Anderson KM: A
cancer DNA phenotype in healthy prostates, conserved in tumors and
adjacent normal cells, implies a relationship to carcinogenesis. Proc Natl
Acad Sci 2005, 102:19093–19096.
54. Galon J, Pagès F, Marincola FM, Thurin M, Trinchieri G, Fox BA, Gajewski TF,
Ascierto PA: The immune score as a new possible approachfor the
classification of cancer. J Transl Med 2012, 3(10):1.
doi:10.1186/1471-2407-13-258
Cite this article as: Yuan et al.: Destructive impact of t-lymphocytes, NK
and mast cells on basal cell layers: implications for tumor invasion. BMC
Cancer 2013 13:258.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
